Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial - Rodríguez-Moreno,J.F.; de Velasco,G.; Álvarez-Fernández,C.; Collado,R.; Fernández,R.; Vázquez,S.; Virizuela,J.A.; Gajate,P.; Font,A.; Lainez,N.; Sevillano-Fernández,E.; Graña-Castro,O.; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)